These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 7691318

  • 1. Successful treatment of Diamond-Blackfan anemia with interleukin 3.
    Gillio AP, Faulkner LB, Alter BP, Reilly L, Klafter R, Heller G, Young DC, Lipton JM, Moore MA, O'Reilly RJ.
    Stem Cells; 1993 Jul; 11 Suppl 2():123-30. PubMed ID: 7691318
    [Abstract] [Full Text] [Related]

  • 2. In vitro enhancement of erythropoiesis by steel factor in Diamond-Blackfan anemia and treatment of other congenital cytopenias with recombinant interleukin 3/granulocyte-macrophage colony stimulating factor.
    Sieff C, Guinan E.
    Stem Cells; 1993 Jul; 11 Suppl 2():113-22. PubMed ID: 7691316
    [Abstract] [Full Text] [Related]

  • 3. Treatment of Diamond-Blackfan anemia with recombinant human interleukin-3.
    Gillio AP, Faulkner LB, Alter BP, Reilly L, Klafter R, Heller G, Young DC, Lipton JM, Moore MA, O'Reilly RJ.
    Blood; 1993 Aug 01; 82(3):744-51. PubMed ID: 8338944
    [Abstract] [Full Text] [Related]

  • 4. Erythropoiesis in Diamond-Blackfan anemia and the role of interleukin 3 and steel factor.
    Freedman MH.
    Stem Cells; 1993 Jul 01; 11 Suppl 2():98-104. PubMed ID: 7691333
    [Abstract] [Full Text] [Related]

  • 5. Effects of recombinant human erythropoietin and interleukin-3 on erythropoietic recovery from acute anemia.
    Rosen BS, Levine EA, Egrie JC, Sehgal LR, Greenberg R, Rosen AL, Levine HD, Gould SA.
    Exp Hematol; 1993 Oct 01; 21(11):1487-91. PubMed ID: 8405228
    [Abstract] [Full Text] [Related]

  • 6. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 01; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 7. Diamond-Blackfan anemia: expansion of erythroid progenitors in vitro by IL-9, but exclusion of a significant pathogenetic role for the IL-9 gene and the hematopoietic gene cluster on chromosome 5q.
    Dianzani I, Garelli E, Crescenzio N, Timeus F, Mori PG, Varotto S, Nobili B, Brandalise S, Olivieri NF, Gabutti V, Ramenghi U.
    Exp Hematol; 1997 Nov 01; 25(12):1270-7. PubMed ID: 9357971
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P, Sanpaolo G, D'Arena G, Scalzulli PR, Matera R, Falcone A, Bodenizza C, Perla G, Carotenuto M.
    Haematologica; 2001 Jan 01; 86(1):44-51. PubMed ID: 11146570
    [Abstract] [Full Text] [Related]

  • 10. Phase I trial of recombinant interleukin 3 before and after carboplatin/etoposide chemotherapy in patients with solid tumors: a southwest oncology group study.
    Rinehart J, Margolin KA, Triozzi P, Hersh E, Campion M, Resta D, Levitt D.
    Clin Cancer Res; 1995 Oct 01; 1(10):1139-44. PubMed ID: 9815905
    [Abstract] [Full Text] [Related]

  • 11. Failure of recombinant human interleukin-3 therapy to induce erythropoiesis in patients with refractory Diamond-Blackfan anemia.
    Olivieri NF, Feig SA, Valentino L, Berriman AM, Shore R, Freedman MH.
    Blood; 1994 May 01; 83(9):2444-50. PubMed ID: 8167334
    [Abstract] [Full Text] [Related]

  • 12. Effects of rhIL-11 on normal dogs and after sublethal radiation.
    Nash RA, Seidel K, Storb R, Slichter S, Schuening FG, Appelbaum FR, Becker AB, Bolles L, Deeg HJ, Graham T.
    Exp Hematol; 1995 May 01; 23(5):389-96. PubMed ID: 7720811
    [Abstract] [Full Text] [Related]

  • 13. Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findings.
    Bukowski RM, Olencki T, Gunn H, McLain D, Budd GT, Sandstrom K, Tuason L, Redovan C, Rayman P, Tubbs R, Resta D, Elson P, Finke J.
    Clin Cancer Res; 1996 Feb 01; 2(2):347-57. PubMed ID: 9816178
    [Abstract] [Full Text] [Related]

  • 14. Diamond-Blackfan anaemia: three patterns of in vitro response to haemopoietic growth factors.
    McGuckin CP, Ball SE, Gordon-Smith EC.
    Br J Haematol; 1995 Mar 01; 89(3):457-64. PubMed ID: 7537525
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Diamond-Blackfan anemia: a congenital defect in erythropoiesis.
    Dianzani I, Garelli E, Ramenghi U.
    Haematologica; 1996 Mar 01; 81(6):560-72. PubMed ID: 9009445
    [Abstract] [Full Text] [Related]

  • 19. Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.
    Atkins MB, Robertson MJ, Gordon M, Lotze MT, DeCoste M, DuBois JS, Ritz J, Sandler AB, Edington HD, Garzone PD, Mier JW, Canning CM, Battiato L, Tahara H, Sherman ML.
    Clin Cancer Res; 1997 Mar 01; 3(3):409-17. PubMed ID: 9815699
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.